ArticleScientific reports2013

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.

Stéphanie Cochaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.